Medicalgorithmics S.A.

Warsaw Stock Exchange MDG.WA

Medicalgorithmics S.A. Price to Sales Ratio (P/S) on January 14, 2025: 3.89

Medicalgorithmics S.A. Price to Sales Ratio (P/S) is 3.89 on January 14, 2025, a 15.98% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Medicalgorithmics S.A. 52-week high Price to Sales Ratio (P/S) is 4.38 on December 03, 2024, which is 12.70% above the current Price to Sales Ratio (P/S).
Medicalgorithmics S.A. 52-week low Price to Sales Ratio (P/S) is 2.01 on November 26, 2024, which is -48.41% below the current Price to Sales Ratio (P/S).
Medicalgorithmics S.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 3.06.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Warsaw Stock Exchange: MDG.WA

Medicalgorithmics S.A.

CEO	Mr. Maciej Gamrot
IPO Date	Nov. 9, 2011
Location	Poland
Headquarters	Central Tower
Employees	120
Sector	Health Care
Industries Medical Instruments Telehealth

Description

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.

Key trends

Past 5 years